The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 09, 2023
Filed:
May. 30, 2019
Applicant:
Shionogi & Co., Ltd., Osaka, JP;
Inventors:
Tatsuya Takahashi, Toyonaka, JP;
Mai Yoshikawa, Toyonaka, JP;
Sosuke Yoneda, Toyonaka, JP;
Junji Onoda, Toyonaka, JP;
Etsuo Nakamura, Toyonaka, JP;
Tsuguo Miyauchi, Toyonaka, JP;
Toshiyuki Asaki, Amagasaki, JP;
Erika Kasai, Toyonaka, JP;
Assignee:
SHIONOGI & CO., LTD., Osaka, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/00 (2006.01); C07K 16/46 (2006.01); C07H 21/04 (2006.01); C12N 5/02 (2006.01); C12N 1/20 (2006.01); C12N 15/00 (2006.01); C07K 16/18 (2006.01); A61P 29/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61P 29/00 (2018.01); A61K 2039/505 (2013.01); C07K 2317/565 (2013.01); C07K 2317/64 (2013.01);
Abstract
Objective of the present invention is to provide a novel monoclonal antibody against Nav1.7. The present invention discloses a monoclonal antibody against Nav1.7 or its antibody fragment, having specific six CDRs (CDR1 to CDR3 of a heavy chain and CDR1 to CDR3 of a light chain) or specific heavy/light chain variable regions. The monoclonal antibody and the like can be used for treating or preventing pain, pruritus and so on.